LIPID PROFILE IN EXPERIMENTAL DIABETES AS A PROMOTING FACTOR IN THROMBOSIS | ||||
Zagazig Journal of Pharmaceutical Sciences | ||||
Article 5, Volume 6, Issue 2, December 1997, Page 23-29 PDF (5.6 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/zjps.1997.184939 | ||||
View on SCiNiTO | ||||
Authors | ||||
Mohamed El-Sweidy 1; Mervat Asker2; Fatma Abdalla2; Hala Mosallamy2 | ||||
1Biochemistry Dept., Faculty of Pharmacy, Zagazig University, Zagazig, Egypt | ||||
2Department of Biochemistry, Faculty of Pharmacy, University of Zagazig, Egypt | ||||
Abstract | ||||
Hyperglycemia has a role in development of tissue hypoxia, a reasonable and a significant factor in atherogenesis. The persent study evaluates this diabetic complications through determination of Glycosylated hemogiobin AI (GHBA1), total cholesterol (Tc), high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), triglyceride (TG), malondialdehyde in erythrocytes membrane (RBCS MDA), Lipoprotein (a) Lp(a)), platelet cholesterol/phospholipid ratio (C/P ratio), fibrinogen, antithrombin II (AT III) and plasminogen. Streptozotocin (STZ) diabetic rats were compared with normal rats. STZ induced significant increase in glucose, GHBA1, Tc, LDLC, Lp(a), RBCS MDA, fibrinogen, plasmirgen and C/P ratio. On the other hand, it significantly decreased the HDLc and AT III This study aimed to correlate blood coagulation factors and changes in lipid and lipoproteins in diabetes mellitus. | ||||
Statistics Article View: 76 PDF Download: 51 |
||||